Zimhi is a Intramuscular; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Uswm, Llc. The primary component is Naloxone Hydrochloride.
Product ID | 78670-140_11da80e4-2e84-40e0-aa63-6f7d5b58405e |
NDC | 78670-140 |
Product Type | Human Prescription Drug |
Proprietary Name | Zimhi |
Generic Name | Naloxone Hydrochloride |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; SUBCUTANEOUS |
Marketing Start Date | 2022-03-15 |
Marketing Category | NDA / |
Application Number | NDA212854 |
Labeler Name | USWM, LLC |
Substance Name | NALOXONE HYDROCHLORIDE |
Active Ingredient Strength | 5 mg/.5mL |
Pharm Classes | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-03-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0093-2165 | Naloxone Hydrochloride | Naloxone Hydrochloride |
0404-9920 | Naloxone Hydrochloride | Naloxone Hydrochloride |
0404-9921 | NALOXONE HYDROCHLORIDE | naloxone hydrochloride |
0404-9922 | NALOXONE HYDROCHLORIDE | naloxone hydrochloride |
0404-9923 | NALOXONE HYDROCHLORIDE | naloxone hydrochloride |
0409-1215 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE |
0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE |
0409-1782 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE |
0641-6205 | Naloxone Hydrochloride | Naloxone Hydrochloride |
17478-041 | Naloxone Hydrochloride | Naloxone Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZIMHI 88281598 not registered Live/Pending |
Adamis Pharmaceuticals Corporation 2019-01-29 |